Caladrius Biosciences, Inc. (LSTA) Tops Q3 EPS by 10c

Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q3 EPS of ($0.49), $0.10 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.

You May Also Be Interested In

• UGI shares spike on reported KKR bid for the company
• S&P affirms Nvidia rating at AA on Ohio campus guarantee
• Amazon: to grow Louisiana data center investment from $12 billion to $18 billion with a third data center campus